Direct Line Insurance Group plc
Direct Line Insurance Group plc (DIISF) Financial Performance & Income Statement Overview
Analyze Direct Line Insurance Group plc (DIISF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Direct Line Insurance Group plc (DIISF) Income Statement & Financial Overview
View the income breakdown for Direct Line Insurance Group plc DIISF across both annual and quarterly reports.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $2.45B | $1.69B | $2.11B | $805.00M |
Cost of Revenue | $2.45B | -$3.05B | -$574.50M | -$350000.00 |
Gross Profit | $0.00 | $4.74B | $2.69B | $805.35M |
Gross Profit Ratio | $0.00 | $2.81 | $1.27 | $1.000 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $3.05B | $0.00 | $0.00 |
Operating Expenses | $0.00 | $3.05B | -$7.00M | $624.55M |
Total Costs & Expenses | -$2.29B | $0.00 | -$2.19B | $624.55M |
Interest Income | $0.00 | $0.00 | $0.00 | $3.60M |
Interest Expense | $8.00M | $7.40M | $7.30M | $0.00 |
Depreciation & Amortization | $0.00 | $141.20M | $62.80M | $17.95M |
EBITDA | $164.80M | $279.20M | $190.65M | $190.65M |
EBITDA Ratio | $0.07 | $0.17 | $0.09 | $0.24 |
Operating Income | $162.10M | $69.60M | -$17.95M | -$17.95M |
Operating Income Ratio | $0.07 | $0.04 | -$0.008 | -$0.02 |
Other Income/Expenses (Net) | -$5.30M | -$8.00M | $371.65M | $194.80M |
Income Before Tax | $156.80M | $61.60M | $353.70M | $176.85M |
Income Before Tax Ratio | $0.06 | $0.04 | $0.17 | $0.22 |
Income Tax Expense | $38.60M | $17.20M | $78.90M | $39.45M |
Net Income | $109.90M | $44.40M | $266.50M | $133.25M |
Net Income Ratio | $0.04 | $0.03 | $0.13 | $0.17 |
EPS | $0.08 | $0.02 | $0.21 | $0.10 |
Diluted EPS | $0.08 | $0.03 | $0.20 | $0.10 |
Weighted Avg Shares Outstanding | $1.30B | $1.64B | $1.30B | $1.31B |
Weighted Avg Shares Outstanding (Diluted) | $1.32B | $1.32B | $1.31B | $1.32B |
Over the past four quarters, Direct Line Insurance Group plc demonstrated steady revenue growth, increasing from $805.00M in Q3 2023 to $2.45B in Q4 2024. Operating income reached $162.10M in Q4 2024, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $164.80M, reflecting operational efficiency. Net income rose to $109.90M, with EPS at $0.08. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan